https://www.selleckchem.com/pr....oducts/Cytarabine(Cy
RTKA survival analysis data is more limited and early results do not allow strong conclusions, however early trends are similar to CAS TKA. Results for CAS-TKA show improvement in alignment, and early clinical outcomes have revealed promising results, with longer-term data and medium-term survival analysis recently emerging showing small benefits over conventional TKA. RTKA represents another phase of development. Early results show similar trends to that of CAS TKA with longer-term data still to come. Results for CAS-TKA
Like
Comment
Share
